A. Kinkaid

发表

Comparison of the catalytic properties of phospholipase A2 from pancreas and venom using a continuous fluorescence displacement assay.

D. Wilton, A. Kinkaid, David C. Wilton, 1991, The Biochemical journal.

Phospholipase D and phosphatidic acid enhance the hydrolysis of phospholipids in vesicles and in cell membranes by human secreted phospholipase A2.

R. Othman, D. Wilton, J. Voysey, 1998, Biochimica et biophysica acta.

Enhanced hydrolysis of phosphatidylcholine by human group II non-pancreatic secreted phospholipase A2 as a result of interfacial activation by specific anions. Potential role of cholesterol sulphate.

D. Wilton, A. Kinkaid, 1995, The Biochemical journal.

Cholesterol-3-sulfate enhances phospholipase A2 activity by promoting interfacial binding.

D. Wilton, J. Voysey, A. Kinkaid, 1997, Biochemical Society transactions.

Cardiolipin hydrolysis by human phospholipases A2. The multiple enzymatic activities of human cytosolic phospholipase A2.

D. Wilton, A. Buckland, A. Kinkaid, 1998, Biochimica et biophysica acta.

Compartmentalisation and characteristics of a Ca2+-dependent phospholipase A2 in human colon mucosa.

D. Wilton, K. Hillier, A. Kinkaid, 1997, Biochemical pharmacology.

A structure-based design approach to the development of novel, reversible AChE inhibitors.

J L Sussman, I Silman, J. Sussman, 2001, Journal of medicinal chemistry.

4-Aminoquinolines as AChE Inhibitors

B. Pirard, P. Bentley, R. Viner, 1998 .

A study of the 14 kDa phospholipase A2 from rat liver using a continuous fluorescent displacement assay for the enzyme.

D. Wilton, A. Kinkaid, 1992, Biochemical Society transactions.

The hydrolysis of phosphatidyl-alcohols by phospholipases A2: effect of head group size and polarity.

D. Wilton, A. Kinkaid, 1997, Biochemical pharmacology.

Comparison of the properties of human group II phospholipase A2 with other secretory phospholipases.

D. Wilton, A. Kinkaid, 1994, Biochemical Society transactions.